These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25741972)

  • 21. The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea.
    Stamboulidis K; Chatzaki D; Poulakou G; Ioannidou S; Lebessi E; Katsarolis I; Sypsa V; Tsakanikos M; Kafetzis D; Tsolia MN
    Pediatr Infect Dis J; 2011 Jul; 30(7):551-5. PubMed ID: 21297521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumococcal conjugate vaccines for preventing otitis media.
    Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2014 Apr; (4):CD001480. PubMed ID: 24696098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic Resistance of Potential Otopathogens Isolated From Nasopharyngeal Flora of Children With Acute Otitis Media Before, During and After Pneumococcal Conjugate Vaccines Implementation.
    Rybak A; Levy C; Bonacorsi S; Béchet S; Vié le Sage F; Elbez A; Varon E; Cohen R
    Pediatr Infect Dis J; 2018 Mar; 37(3):e72-e78. PubMed ID: 29227464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation.
    Cohen R; Varon E; Doit C; Schlemmer C; Romain O; Thollot F; Béchet S; Bonacorsi S; Levy C
    Vaccine; 2015 Sep; 33(39):5118-26. PubMed ID: 26271823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the Seven-valent Pneumococcal Conjugate Vaccine on Acute Otitis Media in Japanese Children: Emergence of Serotype 15A Multidrug-resistant Streptococcus pneumoniae in Middle Ear Fluid Isolates.
    Ozawa D; Yano H; Endo S; Hidaka H; Kakuta R; Okitsu N; Kanamori H; Ogawa M; Ichimura S; Shimojima M; Inomata S; Kaku M; Katori Y
    Pediatr Infect Dis J; 2015 Sep; 34(9):e217-21. PubMed ID: 26083590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
    Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US.
    Shea KM; Weycker D; Stevenson AE; Strutton DR; Pelton SI
    Vaccine; 2011 Oct; 29(45):8042-8. PubMed ID: 21871518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.
    Greenberg D; Givon-Lavi N; Ben-Shimol S; Ziv JB; Dagan R
    Vaccine; 2015 Aug; 33(36):4623-9. PubMed ID: 26116251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Pneumococcal Conjugate Vaccines on Selected Head and Neck Infections in Hospitalized Israeli Children.
    Marom T; Bookstein Peretz S; Schwartz O; Goldfarb A; Oron Y; Tamir SO
    Pediatr Infect Dis J; 2017 Mar; 36(3):314-318. PubMed ID: 27879558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
    Klok RM; Lindkvist RM; Ekelund M; Farkouh RA; Strutton DR
    Clin Ther; 2013 Feb; 35(2):119-34. PubMed ID: 23312274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
    Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pneumococcal vaccine impact on otitis media microbiology: A New Zealand cohort study before and after the introduction of PHiD-CV10 vaccine.
    Best EJ; Walls T; Souter M; Neeff M; Anderson T; Salkeld L; Ahmad Z; Mahadevan M; Walker C; Murdoch D; Mills N
    Vaccine; 2016 Jul; 34(33):3840-7. PubMed ID: 27265454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Prospective, Population-based Study to Determine the Incidence and Bacteriology of Bacterial Conjunctivitis in Children <2 Years of Age Following 7-Valent and 13-Valent Pneumococcal Conjugate Vaccine Sequential Implementation.
    Dagan R; Ben-Shimol S; Greenberg D; Givon-Lavi N
    Clin Infect Dis; 2021 Apr; 72(7):1200-1207. PubMed ID: 32140705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pneumococcal vaccination reduced the risk of acute otitis media: Cohort study.
    Hasegawa J; Mori M; Showa S; Matsushima A; Ohnishi H; Tsugawa T; Yoto Y; Tsutsumi H
    Pediatr Int; 2015 Aug; 57(4):582-5. PubMed ID: 25615843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of pneumococcal conjugate vaccines on acute otitis media in Japan.
    Sasaki A; Kunimoto M; Takeno S; Sumiya T; Ishino T; Sugino H; Hirakawa K
    Auris Nasus Larynx; 2018 Aug; 45(4):718-721. PubMed ID: 29102419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in Otitis Media Incidence After Conjugate Pneumococcal Vaccination: A National Observational Study.
    Gisselsson-Solen M
    Pediatr Infect Dis J; 2017 Nov; 36(11):1027-1031. PubMed ID: 28657970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.
    Cohen R; Levy C; Bingen E; Koskas M; Nave I; Varon E
    Pediatr Infect Dis J; 2012 Mar; 31(3):297-301. PubMed ID: 22330166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: distribution, serotypes, and resistance levels.
    Couloigner V; Levy C; François M; Bidet P; Hausdorff WP; Pascal T; Boucherat M; Bingen E; Mariani P; Pierrot S; Bille E; Carbonnelle E; Varon E; Cohen R
    Pediatr Infect Dis J; 2012 Feb; 31(2):154-8. PubMed ID: 21983212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial etiology of acute otitis media in the era prior to universal pneumococcal vaccination in Taiwanese children.
    Kung YH; Chiu NC; Lee KS; Chang L; Huang DT; Huang FY; Hsieh YC; Huang LM; Chi H
    J Microbiol Immunol Infect; 2014 Jun; 47(3):239-44. PubMed ID: 24080520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current face of acute otitis media: microbiology and prevalence resulting from widespread use of heptavalent pneumococcal conjugate vaccine.
    Brunton S
    Clin Ther; 2006 Jan; 28(1):118-23. PubMed ID: 16490585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.